Long-term treatment data for lecanemab to be presented at AAIC 2024
Go back to Long-term treatment data for lecanemab to be presented at AAIC 2024| BARNES GROUP, Inc. (NYSE: B) | Delayed: 47.60 +1.33 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.27 | 52 Week High | $44.27 | |||
| Open | $47.40 | 52 Week Low | $30.07 | |||
| Day High | $47.79 | P/E | 36.34 | |||
| Day Low | $46.93 | EPS | $1.31 | |||
| Volume | 11,522,091 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 9.48 -0.21 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.69 | 52 Week High | $8.73 | |||
| Open | $9.78 | 52 Week Low | $2.86 | |||
| Day High | $9.92 | P/E | N/A | |||
| Day Low | $9.48 | EPS | $-3.82 | |||
| Volume | 453,445 | |||||
